Dr. Karen Seiter
Claim this profileNew York Medical College
Studies Leukemia
Studies Myeloid Leukemia
7 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Karen Seiter is currently running
Tamibarotene + Azacitidine
for Myelodysplastic Syndrome
This study compares the efficacy of Tamibarotene in combination with azacitidine to azacitidine in combination with placebo in participants who are Retinoic Acid Receptor Alpha (RARA) positive, and newly diagnosed with higher-risk myelodysplastic syndrome (HR-MDS), and who have not received treatment for this diagnosis. The primary goal of the study is to compare the complete remission rate between the two treatment arms.
Recruiting1 award Phase 34 criteria
BP1002
for Lymphoma
This study evaluates the safety, pharmacokinetics, and efficacy of BP1002 (L-Bcl-2) antisense oligonucleotide in patients with advanced lymphoid malignancies. Up to 12 evaluable patients with a diagnosis of relapsed or refractory lymphoid malignancies are expected to participate.
Recruiting1 award Phase 111 criteria
More about Karen Seiter
Clinical Trial Related8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Karen Seiter has experience with
- Tamibarotene
- Azacitidine
- Vodobatinib (K0706)
- Uproleselan
- Cladribine, Cytarabine, Mitoxantrone
- DFP-10917
Breakdown of trials Karen Seiter has run
Leukemia
Myeloid Leukemia
Acute Myeloid Leukemia
Chronic Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karen Seiter specialize in?
Karen Seiter focuses on Leukemia and Myeloid Leukemia. In particular, much of their work with Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Karen Seiter currently recruiting for clinical trials?
Yes, Karen Seiter is currently recruiting for 2 clinical trials in Valhalla New York. If you're interested in participating, you should apply.
Are there any treatments that Karen Seiter has studied deeply?
Yes, Karen Seiter has studied treatments such as Tamibarotene, Azacitidine, Vodobatinib (K0706).
What is the best way to schedule an appointment with Karen Seiter?
Apply for one of the trials that Karen Seiter is conducting.
What is the office address of Karen Seiter?
The office of Karen Seiter is located at: New York Medical College, Valhalla, New York 10595 United States. This is the address for their practice at the New York Medical College.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.